微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 5.3% | -92.94% | 114.57% | 59/158 | 1.25% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 2.47% | -33.6% | 165.59% | 72/158 | 0.28% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 0.93% | 153.45% | -74.45% | 84/158 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 3.64% | 121.81% | -95.15% | 70/158 | -9.6% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 75.04% | 1591.85% | 1917.2% | 2/158 | 4.24% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 3.72% | 431.43% | 313.79% | 54/158 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -1.74% | 14.71% | 89.57% | 127/158 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -16.69% | 80.34% | -231.81% | 129/158 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -5.03% | -115.88% | -818.57% | 126/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 0.7% | 137.43% | 134.31% | 106/158 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -2.04% | -151.85% | 97.6% | 126/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -84.91% | -6436.57% | -3544.21% | 146/158 | 0.72% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -2.33% | -219.49% | -24.6% | 117/158 | 2.84% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -1.87% | -279.81% | -130.86% | 121/158 | 2.19% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -0.81% | -127.46% | -160.45% | 119/158 | 1.58% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 1.34% | -95.71% | -31.28% | 101/158 | 0.79% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 1.95% | -95.7% | 87.5% | 105/158 | 4.44% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 1.04% | -95.32% | -64.75% | 108/158 | 2.97% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.95% | -39.3% | -90.56% | 43/158 | 2.47% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 31.24% | 2% | -31.07% | 3/158 | 3.66% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 45.32% | 13633.33% | 104.05% | 1/158 | 3.07% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 22.21% | -59.05% | 357% | 3/158 | 4.23% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 4.86% | 2% | 2% | 14/158 | 2.2% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-03-31 | 0% | 100% | 2% | 100/158 | 2.43% | 誉衡药业 | 35.56% | 行业排名> |
| 2018-12-31 | 0% | 100% | -100% | 118/158 | 7.17% | 奥赛康 | 35% | 行业排名> |
| 2017-09-30 | 0.33% | 100.19% | -99.39% | 93/158 | 8.34% | 奥赛康 | 28.15% | 行业排名> |
| 2017-06-30 | 54.24% | 149.41% | 4942.86% | 1/158 | 5.62% | 宏源药业 | 21.91% | 行业排名> |
| 2017-03-31 | -1.12% | -105.81% | 99.78% | 83/158 | 2.1% | 奥赛康 | 9.7% | 行业排名> |
| 2016-12-31 | -504.73% | -743.47% | -188.09% | 111/158 | 6.22% | 奥赛康 | 40.69% | 行业排名> |
| 2016-09-30 | -175.2% | -477.84% | -59.59% | 80/158 | 5.64% | 信立泰 | 25.93% | 行业排名> |
| 2016-06-30 | -109.78% | -716.82% | -669.1% | 89/158 | 3.52% | 昂利康 | 15.91% | 行业排名> |
| 2016-03-31 | 19.29% | 355.84% | 132.24% | 1/158 | 2.69% | 奥赛康 | 12.08% | 行业排名> |